Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02410317Phase 3Completed
A Phase 3 trial of ropivacaine in postoperative pain, sponsored by CHU Grenoble Alpes. Started Feb 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02410317.